News
Andy Byron, the now-former CEO of the data analytics firm Astronomer, has found himself at the center of an even messier viral firestorm. While the co-stars denied fans' requests for photos while ...
Gov. Glenn Youngkin speaks with Janet Roach about pharmaceutical company AstraZeneca building a facility in Virginia.
Billy Joel’s 1st Wife Speaks Out About Their Marriage — and Why She Left ...
AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...
The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...
Solvay S.A. (Brussels, Belgium) has taken a new step to reduce scope 3 greenhouse gas emissions by incorporating biogenic CO₂ ...
Explore more
AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...
AstraZeneca PLC Sponsored ADR (AZN) is currently at $72.92, up $2.44 or 3.46% --Would be highest close since June 16, 2025, when it closed at $73.55 --On pace for largest percent increase since April ...
Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med. | Ahead of the 10-year ...
AstraZeneca's AZN +2.30% Get Free Report short percent of float has fallen 8.33% since its last report. The company recently reported that it has 6.81 million shares sold short, which is 0.22% of all ...
Meanwhile, President Trump continues to push reciprocal levies and reshoring efforts, while pharma prepares for escalating costs.
The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results